ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,722Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 1499

$522K Total Retail Price of All Prescriptions

Rank: 318 out of 1499

501 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,825 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
FUROSEMIDE 466 339 1 7
OMEPRAZOLE 465 303 2 5
HYDROCODONE-ACETAMINOPHEN 451 249 S3 3 4
LEVOTHYROXINE SODIUM 426 316 4 2
LISINOPRIL 370 243 5 1
AMLODIPINE BESYLATE 307 245 6 6
SIMVASTATIN 283 220 7 3
RANITIDINE HCL 240 163 8 15
POTASSIUM CHLORIDE 221 162 9 11
WARFARIN SODIUM 208 150 10 12
METFORMIN HCL 207 132 11 8
LOVASTATIN 189 136 12 19
METOPROLOL TARTRATE 158 110 13 10
METOPROLOL SUCCINATE 152 113 14 20
TAMSULOSIN HCL 149 125 15 29
HYDROCHLOROTHIAZIDE 141 106 16 9
ALLOPURINOL 139 101 17 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 89 18 25
ATENOLOL 127 100 19 21
ADVAIR DISKUS 109 67 20 37
TRAMADOL HCL 109 55 20 16
CLOPIDOGREL 107 94 22 39
GABAPENTIN 106 68 23 13
ATORVASTATIN CALCIUM 102 62 24 17
DONEPEZIL HCL 96 96 25 35
GLYBURIDE 89 89 R 26 69
DIGOXIN 88 82 27 56
PAROXETINE HCL 87 68 28 59
PROPRANOLOL HCL 85 56 29 115
ZOLPIDEM TARTRATE 83 51 30 23
NEXIUM 82 30 31 28
DICLOFENAC SODIUM 81 74 32 131
PROAIR HFA 80 27 33 30
PLAVIX 79 68 34 54
ISOSORBIDE MONONITRATE ER 75 75 35 51
CARVEDILOL 75 75 35 22
IBUPROFEN 73 35 37 70
GLIPIZIDE 68 61 38 64
KLOR-CON M10 67 43 39 176
CLONIDINE HCL 67 52 39 57
LYRICA 66 19 41 90
LANTUS 66 42 41 46
ROPINIROLE HCL 63 36 43 55
KLOR-CON M20 62 47 44 97
TAMIFLU 60 52 45 279
TRAMADOL HCL-ACETAMINOPHEN 60 37 45 162
PREDNISONE 58 45 47 42
AZITHROMYCIN 58 41 47 45
BUSPIRONE HCL 57 52 49 94
SERTRALINE HCL 55 41 50 24
PRAVASTATIN SODIUM 53 50 51 18
CYMBALTA 52 13 52 40
ALENDRONATE SODIUM 52 49 52 33
BYSTOLIC 51 37 54 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.